Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Ann Surg Oncol. 2010 Jun;17(6):1490-8. doi: 10.1245/s10434-010-1017-0. Epub 2010 Mar 12.
Surgery is the mainstay of treatment for medullary thyroid cancer (MTC), with long-term patient outcomes associated with adequacy of resection. This study benchmarked national practice patterns against 2009 American Thyroid Association (ATA) guidelines for MTC regarding use of thyroidectomy, lymphadenectomy, radioactive iodine (RAI), and external-beam radiotherapy (EBRT).
This is a cross-sectional, retrospective cohort study of MTC patients in the Surveillance, Epidemiology, and End Results Program database, 1973 to 2006. ATA recommendations 61 to 66 (extent of surgery), 85 (RAI), and 93 (EBRT) were analyzed. Outcome of interest was practice accordance with these recommendations. Predictors of accordance were determined and Kaplan-Meier survival analyses were performed.
A total of 2033 patients with MTC were identified. Fifty-nine percent were women; 78% were white. Forty-one percent of patients did not receive appropriate surgical therapy (recommendations 61 to 63). Most patients with distant metastatic disease had less aggressive surgery and more EBRT (P < 0.001) (recommendations 64 to 66). Four percent of patients received inappropriate RAI (recommendation 85). Two hundred nine patients had gross incomplete resections, with 33% receiving postoperative EBRT (recommendation 93). Statistically significant predictors of receiving surgery discordant with ATA recommendations in multivariate analysis were patient age >65, female sex, earlier year of diagnosis (1988 to 1997), geographic region, intrathyroidal tumor extent, and tumor size of </=1 cm. Patients receiving surgery discordant with recommendations had shorter survival than those receiving surgery according to recommendations (P < 0.05).
Variation in practice patterns exist in the United States with regard to extent of surgery and lymphadenectomy for MTC. Dissemination of standardized guidelines is important to ensure optimal treatment with less variation in quality of care.
手术是治疗甲状腺髓样癌(MTC)的主要手段,长期的患者预后与切除的充分性有关。本研究根据 2009 年美国甲状腺协会(ATA)关于 MTC 的指南,针对甲状腺切除术、淋巴结切除术、放射性碘(RAI)和外照射放疗(EBRT)的使用情况,对全国的实践模式进行了基准测试。
这是一项针对 1973 年至 2006 年监测、流行病学和最终结果(SEER)数据库中 MTC 患者的横断面、回顾性队列研究。分析了 ATA 建议 61 至 66(手术范围)、85(RAI)和 93(EBRT)。感兴趣的结果是与这些建议的一致性。确定了符合的预测因素,并进行了 Kaplan-Meier 生存分析。
共确定了 2033 例 MTC 患者。59%为女性;78%为白人。41%的患者未接受适当的手术治疗(建议 61 至 63)。大多数远处转移疾病患者的手术侵袭性较小,EBRT 较多(P < 0.001)(建议 64 至 66)。4%的患者接受了不适当的 RAI(建议 85)。209 例患者有大体不完全切除,其中 33%在术后接受 EBRT(建议 93)。多变量分析中,与 ATA 建议不符的手术接受情况的统计学显著预测因素为患者年龄>65 岁、女性、诊断年份较早(1988 年至 1997 年)、地理位置、甲状腺内肿瘤范围和肿瘤大小<=1cm。与建议不符的手术患者的生存时间短于符合建议的手术患者(P < 0.05)。
美国在 MTC 的手术范围和淋巴结切除术方面存在实践模式的差异。传播标准化指南对于确保最佳治疗效果和减少护理质量差异非常重要。